instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungaemia'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal infection'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver disorder'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung disorder'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Second primary malignancy'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Soft tissue infection'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unevaluable event'. | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | CARFILZOMIB, DEXAMETHASONE, FILGRASTIM, LENALIDOMIDE, MELPHALAN | DrugsGivenReaction | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
What was the administration route of drug 'CARFILZOMIB'? | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
What was the administration route of drug 'DEXAMETHASONE'? | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
What was the dosage of drug 'DEXAMETHASONE'? | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | 40 MILLIGRAM , 1, 8, 15, AND 22 OF 28-DAY CYCLES. | DrugDosageText | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
What was the outcome of reaction 'Death'? | Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Salvage high-dose chemotherapy and autologous stem cell transplantation (HDCT/ASCT) is a treatment option for relapsed and/or refractory multiple myel... | Fatal | ReactionOutcome | CC BY | 34572934 | 19,924,457 | 2021-09-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchial injury'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Emphysema'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nodule'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IMMUNE GLOBULIN NOS, IXAZOMIB, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573225 | 19,913,466 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IMMUNE GLOBULIN NOS, IXAZOMIB, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573225 | 19,913,466 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, IXAZOMIB, RIVAROXABAN | DrugsGivenReaction | CC BY | 34573225 | 19,951,532 | 2021-09-13 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34573225 | 19,913,466 | 2021-09-13 |
What was the dosage of drug 'DEXAMETHASONE'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | 5 CYCLES | DrugDosageText | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
What was the outcome of reaction 'Brain abscess'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,951,532 | 2021-09-13 |
What was the outcome of reaction 'Bronchial injury'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
What was the outcome of reaction 'Emphysema'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
What was the outcome of reaction 'Nocardiosis'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
What was the outcome of reaction 'Nodule'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
What was the outcome of reaction 'Pneumonitis'? | Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
Nocardia brain abscess is relatively rare, accounting for about 1-2% of all brain abscesses, and its mortality rate is three times higher than of other types of bacterial brain a... | Recovering | ReactionOutcome | CC BY | 34573225 | 19,948,182 | 2021-09-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,111,824 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anger'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,111,824 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,115,333 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,111,826 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | ARIPIPRAZOLE, FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,111,905 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | ESCITALOPRAM OXALATE | DrugsGivenReaction | CC BY | 34573236 | 20,123,173 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mania'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,114,209 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychotic disorder'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | ARIPIPRAZOLE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,115,333 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tearfulness'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | ESCITALOPRAM OXALATE | DrugsGivenReaction | CC BY | 34573236 | 20,123,173 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | FLUOXETINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573236 | 20,111,824 | 2021-09-15 |
What was the outcome of reaction 'Mania'? | Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study.
BACKGROUND
Depression is a common psychiatric comorbidity in individuals with Down syndrome (DS), particularly adults, with an estimated lifetime prevalence of at least 1... | Recovering | ReactionOutcome | CC BY | 34573236 | 20,115,680 | 2021-09-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | ACETAMINOPHEN, PENTAZOCINE, TRAMADOL | DrugsGivenReaction | CC BY | 34573886 | 20,667,614 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | ACETAMINOPHEN, PENTAZOCINE, TRAMADOL | DrugsGivenReaction | CC BY | 34573886 | 20,667,614 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | ACETAMINOPHEN, PENTAZOCINE, TRAMADOL | DrugsGivenReaction | CC BY | 34573886 | 20,667,668 | 2021-08-25 |
What was the administration route of drug 'ACETAMINOPHEN'? | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | Transplacental | DrugAdministrationRoute | CC BY | 34573886 | 20,667,614 | 2021-08-25 |
What was the administration route of drug 'PENTAZOCINE'? | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | Transplacental | DrugAdministrationRoute | CC BY | 34573886 | 20,667,614 | 2021-08-25 |
What was the administration route of drug 'TRAMADOL'? | Incarcerated Gravid Uterus: Spontaneous Resolution Is Not Rare.
OBJECTIVE
Incarcerated gravid uterus is a rare obstetrical complication that leads to adverse outcomes, especially if the uterus remains incarcerated and the condition goes undiagnosed until delivery. However, there is no consensus regarding the optimal ma... | Transplacental | DrugAdministrationRoute | CC BY | 34573886 | 20,667,614 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anti-neutrophil cytoplasmic antibody positive vasculitis'. | Methimazole-Induced ANCA Vasculitis: A Case Report.
Rapidly progressive glomerulonephritis (RPGN) is a syndrome which presents rapid loss of renal function. Vasculitis represents one of the major causes, often related to anti-neutrophil cytoplasmic antibodies (ANCA). Herein, we report a case of methimazole-induced ANCA... | CEFTRIAXONE, METHIMAZOLE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573922 | 20,373,151 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis rapidly progressive'. | Methimazole-Induced ANCA Vasculitis: A Case Report.
Rapidly progressive glomerulonephritis (RPGN) is a syndrome which presents rapid loss of renal function. Vasculitis represents one of the major causes, often related to anti-neutrophil cytoplasmic antibodies (ANCA). Herein, we report a case of methimazole-induced ANCA... | CEFTRIAXONE, METHIMAZOLE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34573922 | 20,373,151 | 2021-08-31 |
What was the outcome of reaction 'Anti-neutrophil cytoplasmic antibody positive vasculitis'? | Methimazole-Induced ANCA Vasculitis: A Case Report.
Rapidly progressive glomerulonephritis (RPGN) is a syndrome which presents rapid loss of renal function. Vasculitis represents one of the major causes, often related to anti-neutrophil cytoplasmic antibodies (ANCA). Herein, we report a case of methimazole-induced ANCA... | Recovered | ReactionOutcome | CC BY | 34573922 | 20,373,151 | 2021-08-31 |
What was the outcome of reaction 'Glomerulonephritis rapidly progressive'? | Methimazole-Induced ANCA Vasculitis: A Case Report.
Rapidly progressive glomerulonephritis (RPGN) is a syndrome which presents rapid loss of renal function. Vasculitis represents one of the major causes, often related to anti-neutrophil cytoplasmic antibodies (ANCA). Herein, we report a case of methimazole-induced ANCA... | Recovered | ReactionOutcome | CC BY | 34573922 | 20,373,151 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Long-Term Clinical and Multimodal Imaging Findings in Patients with Disseminated Mycobacterium Chimaera Infection.
BACKGROUND
To analyze long-term ophthalmic clinical and multimodal imaging findings of disseminated Mycobacterium (M.) chimaera infection after cardiothoracic surgery among the Swiss Cohort.
METHODS
Syst... | CLARITHROMYCIN, ETHAMBUTOL HYDROCHLORIDE, MOXIFLOXACIN, RIFABUTIN | DrugsGivenReaction | CC BY | 34575289 | 20,485,647 | 2021-09-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mycobacterial infection'. | Long-Term Clinical and Multimodal Imaging Findings in Patients with Disseminated Mycobacterium Chimaera Infection.
BACKGROUND
To analyze long-term ophthalmic clinical and multimodal imaging findings of disseminated Mycobacterium (M.) chimaera infection after cardiothoracic surgery among the Swiss Cohort.
METHODS
Syst... | BEDAQUILINE, CLARITHROMYCIN, ETHAMBUTOL HYDROCHLORIDE, RIFABUTIN | DrugsGivenReaction | CC BY | 34575289 | 20,553,505 | 2021-09-16 |
What was the outcome of reaction 'Drug ineffective'? | Long-Term Clinical and Multimodal Imaging Findings in Patients with Disseminated Mycobacterium Chimaera Infection.
BACKGROUND
To analyze long-term ophthalmic clinical and multimodal imaging findings of disseminated Mycobacterium (M.) chimaera infection after cardiothoracic surgery among the Swiss Cohort.
METHODS
Syst... | Fatal | ReactionOutcome | CC BY | 34575289 | 20,485,647 | 2021-09-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its related disease (COVID-19) continue to represent a challenge for humans. To date, vaccination programs have represented an opportunity to navigate the pandemic. ... | RITUXIMAB, TOZINAMERAN | DrugsGivenReaction | CC BY | 34577814 | 19,999,254 | 2021-08-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunodeficiency'. | COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its related disease (COVID-19) continue to represent a challenge for humans. To date, vaccination programs have represented an opportunity to navigate the pandemic. ... | RITUXIMAB, TOZINAMERAN | DrugsGivenReaction | CC BY | 34577814 | 19,999,254 | 2021-08-27 |
What was the dosage of drug 'TOZINAMERAN'? | COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its related disease (COVID-19) continue to represent a challenge for humans. To date, vaccination programs have represented an opportunity to navigate the pandemic. ... | DOSE 1, SINGLE | DrugDosageText | CC BY | 34577814 | 19,999,254 | 2021-08-27 |
What was the outcome of reaction 'COVID-19 pneumonia'? | COVID-19 Pneumonia in Vaccinated Population: A Six Clinical and Radiological Case Series.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its related disease (COVID-19) continue to represent a challenge for humans. To date, vaccination programs have represented an opportunity to navigate the pandemic. ... | Not recovered | ReactionOutcome | CC BY | 34577814 | 19,999,254 | 2021-08-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'CYP2D6 polymorphism'. | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | ACETAMINOPHEN, ALLOPURINOL, AMLODIPINE BESYLATE, APIXABAN, CALCITRIOL, CHOLECALCIFEROL, CLONIDINE, DICLOFENAC, DRONEDARONE, DULOXETINE, FUROSEMIDE, GABAPENTIN, HYDROCODONE, INSULIN ASPART, INSULIN GLARGINE, LEVOTHYROXINE, LIDOCAINE, LOPERAMIDE, MELATONIN, METOPROLOL, METOPROLOL TARTRATE, NYSTATIN, ONDANSETRON, PANTOPRA... | DrugsGivenReaction | CC BY | 34577878 | 19,992,976 | 2021-09-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect decreased'. | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | ACETAMINOPHEN, ACETAMINOPHEN\HYDROCODONE, ALLOPURINOL, AMLODIPINE BESYLATE, APIXABAN, CALCITRIOL, CHOLECALCIFEROL, CLONIDINE, DICLOFENAC, DRONEDARONE, DULOXETINE, FUROSEMIDE, GABAPENTIN, INSULIN ASPART, INSULIN GLARGINE, LEVOTHYROXINE, LIDOCAINE, LOPERAMIDE, MELATONIN, METOPROLOL TARTRATE, NYSTATIN, ONDANSETRON, PANTOP... | DrugsGivenReaction | CC BY | 34577878 | 20,010,813 | 2021-09-10 |
What was the administration route of drug 'ACETAMINOPHEN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'ACETAMINOPHEN\HYDROCODONE BITARTRATE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,055,960 | 2021-09-10 |
What was the administration route of drug 'ACETAMINOPHEN\HYDROCODONE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'ALLOPURINOL'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'APIXABAN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'ASCORBIC ACID'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,055,960 | 2021-09-10 |
What was the administration route of drug 'CALCITRIOL'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'CAMPHOR'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Topical | DrugAdministrationRoute | CC BY | 34577878 | 20,055,960 | 2021-09-10 |
What was the administration route of drug 'CHOLECALCIFEROL'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'CLONIDINE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'DICLOFENAC'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Topical | DrugAdministrationRoute | CC BY | 34577878 | 19,991,734 | 2021-09-10 |
What was the administration route of drug 'DRONEDARONE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'DULOXETINE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'FUROSEMIDE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'GABAPENTIN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'HYDROCODONE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 19,992,976 | 2021-09-10 |
What was the administration route of drug 'INSULIN ASPART'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Subcutaneous | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'INSULIN GLARGINE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Subcutaneous | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'LEVOTHYROXINE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'LOPERAMIDE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'MELATONIN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'METOPROLOL TARTRATE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 19,991,734 | 2021-09-10 |
What was the administration route of drug 'METOPROLOL'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'NYSTATIN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'ONDANSETRON'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'PANTOPRAZOLE'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the administration route of drug 'VALSARTAN'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | Oral | DrugAdministrationRoute | CC BY | 34577878 | 20,005,154 | 2021-09-10 |
What was the dosage of drug 'ASCORBIC ACID'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | 125 MILLIGRAM, ONCE A DAY | DrugDosageText | CC BY | 34577878 | 20,055,960 | 2021-09-10 |
What was the dosage of drug 'CAMPHOR'? | Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This repor... | 1 DOSAGE FORM, TWO TIMES A DAY | DrugDosageText | CC BY | 34577878 | 20,055,960 | 2021-09-10 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.